These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31016515)

  • 1. HDAC-selective Inhibitor Cay10603 Has Single Anti-tumour Effect in Burkitt's Lymphoma Cells by Impeding the Cell Cycle.
    Ma XJ; Xu G; Li ZJ; Chen F; Wu D; Miao JN; Zhan Y; Fan Y
    Curr Med Sci; 2019 Apr; 39(2):228-236. PubMed ID: 31016515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma.
    Wang Z; Tang F; Hu P; Wang Y; Gong J; Sun S; Xie C
    Oncol Rep; 2016 Jul; 36(1):589-97. PubMed ID: 27221381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway.
    Hu T; Gao Y
    Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
    Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Antiproliferative and Pro-Apoptotic Effects of Nitrostyrenes and Related Compounds in Burkitt's Lymphoma.
    Byrne AJ; Bright SA; Fayne D; McKeown JP; McCabe T; Twamley B; Williams C; Meegan MJ
    Med Chem; 2018 Feb; 14(2):181-199. PubMed ID: 28969575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity.
    Gaisina IN; Tueckmantel W; Ugolkov A; Shen S; Hoffen J; Dubrovskyi O; Mazar A; Schoon RA; Billadeau D; Kozikowski AP
    ChemMedChem; 2016 Jan; 11(1):81-92. PubMed ID: 26592932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ouabain induces apoptosis and autophagy in Burkitt's lymphoma Raji cells.
    Meng L; Wen Y; Zhou M; Li J; Wang T; Xu P; Ouyang J
    Biomed Pharmacother; 2016 Dec; 84():1841-1848. PubMed ID: 27894666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
    Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 6 activity is critical for the metastasis of Burkitt's lymphoma cells.
    Ding N; Ping L; Feng L; Zheng X; Song Y; Zhu J
    Cancer Cell Int; 2014; 14(1):139. PubMed ID: 25546298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
    Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
    Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of trichostatin A on Burkitt's lymphoma cells: Inhibition of EPS8 activity through Phospho-Erk1/2 pathway.
    Sun P; Zhou X; He Y; Liu H; Wang Y; Chen Y; Li M; He Y; Li G; Li Y
    Biochem Biophys Res Commun; 2018 Mar; 497(4):990-996. PubMed ID: 29462617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal model.
    Wang T; Xu P; Wang F; Zhou D; Wang R; Meng L; Wang X; Zhou M; Chen B; Ouyang J
    Leuk Lymphoma; 2017 Jul; 58(7):1673-1685. PubMed ID: 28084852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cells.
    Tomoyasu C; Kikuchi K; Kaneda D; Yagyu S; Miyachi M; Tsuchiya K; Iehara T; Sakai T; Hosoi H
    Oncol Rep; 2019 Jan; 41(1):643-649. PubMed ID: 30365145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription.
    Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
    Xie R; Li Y; Tang P; Yuan Q
    Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
    Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
    Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma.
    Wang N; Zeng GZ; Yin JL; Bian ZX
    Biochem Biophys Res Commun; 2019 Nov; 519(3):533-539. PubMed ID: 31537387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor.
    North BJ; Almeciga-Pinto I; Tamang D; Yang M; Jones SS; Quayle SN
    PLoS One; 2017; 12(3):e0173507. PubMed ID: 28264055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.